These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12368366)

  • 1. Bone lymphoma: 67Ga scintigraphy and CT for prediction of outcome after treatment.
    Israel O; Mekel M; Bar-Shalom R; Epelbaum R; Hermony N; Haim N; Dann EJ; Frenkel A; Ben-Arush M; Gaitini D
    J Nucl Med; 2002 Oct; 43(10):1295-303. PubMed ID: 12368366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive non-Hodgkin lymphoma: early prediction of outcome with 67Ga scintigraphy.
    Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
    Radiology; 2000 Jan; 214(1):253-7. PubMed ID: 10644133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
    Gasparini M; Bombardieri E; Castellani M; Tondini C; Maffioli L; Devizzi L; Gerundini P
    J Nucl Med; 1998 Sep; 39(9):1586-90. PubMed ID: 9744348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy.
    Front D; Bar-Shalom R; Mor M; Haim N; Epelbaum R; Frenkel A; Gaitini D; Kolodny GM; Israel O
    Radiology; 1999 Feb; 210(2):487-91. PubMed ID: 10207434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of bone and 67Ga scintigraphy in the initial diagnosis of bone involvement in children with malignant lymphoma.
    Mouratidis B; Gilday DL; Ash JM
    Nucl Med Commun; 1994 Mar; 15(3):144-7. PubMed ID: 8190402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
    Chajari M; Lacroix J; Peny AM; Chesnay E; Batalla A; Henry-Amar M; Delcambre C; Génot JY; Fruchard C; Bardet S
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):380-7. PubMed ID: 12002715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoma: predictive value of Ga-67 scintigraphy after treatment.
    Front D; Ben-Haim S; Israel O; Epelbaum R; Haim N; Even-Sapir E; Kolodny GM; Robinson E
    Radiology; 1992 Feb; 182(2):359-63. PubMed ID: 1732950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of gallium-67-citrate and thallium-201 scintigraphy in peripheral and intrathoracic lymphoma.
    Waxman AD; Eller D; Ashook G; Ramanna L; Brachman M; Heifetz L; McAndrews P; Bierman H; Taub R; Avedo M; Wall F
    J Nucl Med; 1996 Jan; 37(1):46-50. PubMed ID: 8544000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The continuing clinical role of gallium 67 scintigraphy in the age of receptor imaging.
    Front D; Bar-Shalom R; Israel O
    Semin Nucl Med; 1997 Jan; 27(1):68-74. PubMed ID: 9122725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 67Ga scintigraphy for the evaluation of recurrences and residual masses in patients with lymphoma.
    Setoain FJ; Pons F; Herranz R; Vidal-Sicart S; Lomeña F; Ayuso C; Montserrat E; Setoain J
    Nucl Med Commun; 1997 May; 18(5):405-11. PubMed ID: 9194081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease.
    Kostakoglu L; Coleman M; Leonard JP; Kuji I; Zoe H; Goldsmith SJ
    J Nucl Med; 2002 Aug; 43(8):1018-27. PubMed ID: 12163626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18FDG PET versus high-dose 67Ga scintigraphy for restaging and treatment follow-up of lymphoma patients.
    Van Den Bossche B; Lambert B; De Winter F; Kolindou A; Dierckx RA; Noens L; Van De Wiele C
    Nucl Med Commun; 2002 Nov; 23(11):1079-83. PubMed ID: 12411836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy.
    Brenot-Rossi I; Bouabdallah R; Di Stefano D; Bardou VJ; Stoppa AM; Camerlo J; Sauvan R; Gastaut JA; Pasquier J
    Eur J Nucl Med; 2001 Oct; 28(10):1482-8. PubMed ID: 11685490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.
    Escobar IG; Barrigon DC; Tamayo P; Perez-Simon JA; Mateos MV; Garcia JR; San Miguel JF
    Clin Lymphoma Myeloma; 2006 Nov; 7(3):217-25. PubMed ID: 17229338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When is hilar uptake of 67Ga-citrate indicative of residual disease after CHOP chemotherapy?
    Frohlich DE; Chen JL; Neuberg D; Kehoe KM; Van den Abbeele AD
    J Nucl Med; 2000 Feb; 41(2):269-74. PubMed ID: 10688110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of gallium-67 scintigraphy in low-grade non-Hodgkin's lymphoma.
    Ben-Haim S; Bar-Shalom R; Israel O; Haim N; Epelbaum R; Ben-Shachar M; Gaitini D; Kolodny GM; Front D
    J Clin Oncol; 1996 Jun; 14(6):1936-42. PubMed ID: 8656263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging and monitoring of malignant lymphoma of the bone: comparison of 67Ga scintigraphy and MRI.
    Stroszczynski C; Oellinger J; Hosten N; Spahn G; Amthauer H; Ricke J; Hoffmann KT; Eichstaedt H; Ludwig WD; Felix R
    J Nucl Med; 1999 Mar; 40(3):387-93. PubMed ID: 10086700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [SPECT-CT 67Ga studies in lymphoma disease. Contribution to staging and follow-up].
    Fuertes Manuel J; Estorch Cabrera M; Camacho Martí V; Flotats Giralt A; Rodríguez-Revuelto AA; Hernández Fructuoso MA; Carrió Gasset I
    Rev Esp Med Nucl; 2006; 25(4):242-9. PubMed ID: 16827987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of high dose 67-gallium scintigraphy in staging untreated patients with lymphoma.
    Larcos G; Farlow DC; Antico VF; Gruenewald SM; Boyages J
    Aust N Z J Med; 1994 Feb; 24(1):5-8. PubMed ID: 8002858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.